All News about Cytokinetics
![](/next-assets/images/schema-image-default.png)
18 Analysts Have This to Say About Cytokinetics
May 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1701.png?width=1200&height=800&fit=crop)
Cytokinetics: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Cytokinetics
April 18, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Cytokinetics's Future
March 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/31/cytk.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Cytokinetics
March 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/06/cytk_logo_light__130d3b89d0db0fa7563fb674d4d3b94d.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/cytk_logo_light__130d3b89d0db0fa7563fb674d4d3b94d.png?width=1200&height=800&fit=crop)
FDA Rejects Cytokinetics' Heart Failure Treatment Candidate
March 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Cytokinetics's Earnings: A Preview
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Cytokinetics
February 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30925.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Cytokinetics
December 20, 2022
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023
February 17, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/02/TECJ1_Eliquis_021723_shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/31/biotech_shutter.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30889.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Cytokinetics
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/27/photo_by_nednapa_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image-tesla4_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30880.jpeg?width=1200&height=800&fit=crop)
What 7 Analyst Ratings Have To Say About Cytokinetics
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/14/cytk_logo_light__130d3b89d0db0fa7563fb674d4d3b94d.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/14/cytokinetics-logo-rgb-1-jpg.jpg?width=1200&height=800&fit=crop)
FDA Adcomm Gives Thumbs Down To Cytokinetics' Heart Failure Candidate
December 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5341.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/14/image-rev_group.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/14/image_6.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-Cytokinetics-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/14/jack_dorsey_david_shankbone_2010.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/01/shutterstock_1599868912.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-Cytokinetics-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27899.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.